Position in TECH
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$12,702,418
+$327,796 QoQ
Shares Held
243,062
+15.5% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Derivatives in TECH
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$1,254,240
PutShares
24,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. TECH ranks #17 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in TECH
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,702,418 | 243,062 | Shares | Defined | 2026-05-11 | |
| 2026-03-31 | $1,254,240 | 24,000 | Put | Defined | 2026-05-11 | |
| 2025-12-31 | $12,374,622 | 210,417 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $8,354,289 | 150,176 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,654,820 | 51,600 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $2,534,991 | 49,271 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,617,471 | 61,700 | Call | Defined | 2025-05-13 | |
| 2025-03-31 | $2,781,698 | 47,445 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,702,123 | 51,397 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,891,802 | 86,223 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $5,278,382 | 73,669 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,168,273 | 87,630 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $6,363,770 | 82,475 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,843,912 | 56,470 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,362,943 | 90,199 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $6,345,394 | 85,529 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $14,483,527 | 174,753 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,840,639 | 40,009 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,756,883 | 43,352 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,321,940 | 95,344 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,561,956 | 58,468 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $31,375,056 | 258,993 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $24,053,448 | 213,685 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $22,795,585 | 238,741 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $18,466,403 | 232,611 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $12,593,476 | 203,342 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $3,245,419 | 49,160 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,542,044 | 53,624 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||